Table 4 Multivariate analysis of immune cell position according to clinicopathological characteristics.
From: Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent
Immune cell position (n = 131) | ||||||
|---|---|---|---|---|---|---|
Touching* (n = 47) | Intraductal* (n = 30) | |||||
OR | 95% CI | P-value | OR | 95% CI | P-value | |
Age | 0.96 | 0.93–0.99 | 0.013 | 0.97 | 0.93–1.02 | 0.207 |
Size (missing n = 17; cm) | 1.05 | 0.92–1.20 | 0.472 | 1.17 | 0.99–1.39 | 0.067 |
Growth pattern | 1.84 | 1.10–3.08 | 0.020 | 1.57 | 0.77–3.19 | 0.216 |
Grade | 1.41 | 0.75–2.63 | 0.287 | 0.57 | 0.26–1.26 | 0.161 |
Calcification | 0.87 | 0.40–1.89 | 0.723 | 0.74 | 0.26–2.13 | 0.577 |
Comedonecrosis | 0.32 | 0.16–0.64 | 0.001 | 0.58 | 0.21–1.56 | 0.280 |
IHC DCIS subtype (missing n = 3) | 1.05 | 0.75–1.47 | 0.776 | 1.29 | 0.80–2.09 | 0.300 |
Ipsilateral recurence (missing n = 5) | 0.64 | 0.11–3.74 | 0.620 | 0.94 | 0.09–9.09 | 0.956 |